Depression-like and anxiety-related behaviour of rats fed with magnesium-deficient diet

Zhurnal Vysshei Nervnoi Deyatelnosti Imeni I.P. Pavlova

Volumn 58, Issue 4, 2008, Pages 476-485

  Spasov, A A ^a   Iezhitsa, I N ^a   Kharitonova, M V ^a   Kravchenko, M S ^a  

^a VOLGOGRAD STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Depression like and anxiety related behavior; Elevated plus maze test; Forced swimming test; Magnesium; Magnesium deficiency; Magnesium deficient diet; Pyridoxine hydrochloride; Rats; The open field test

Indexed keywords

ASPARTIC ACID; MAGNESIUM DERIVATIVE;

ANIMAL; ANXIETY; ARTICLE; DEPRESSION; DIET SUPPLEMENTATION; MAGNESIUM DEFICIENCY; MALE; PATHOPHYSIOLOGY; RAT;

ANIMALS; ANXIETY; ASPARTIC ACID; DEPRESSION; DIETARY SUPPLEMENTS; MAGNESIUM COMPOUNDS; MAGNESIUM DEFICIENCY; MALE; RATS;

EID: 54149106934     PISSN: 00444677     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Russian source
2. Russian source
3. Banki C.M., Vojnik M., Papp Z., Balla KZ., Arato M. Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol. Psychiatry. 1985. 20: 163-171.
4. Basarsky T.A., Duffy S.N., Andrew R.D., MacVicar B.A. Imaging spreading depression and associated intracellular calcium waves in brain slices. J. Neurosci. 1998. 18:7189-7199.
5. Bureš Y., Burešová O., Huston J.P. Techniques and basic experiments for the study of brain and behavior. Amsterdam, New York: Elsevier Sci. Publ. B.V. 1983. 277 p.
6. Chouinard G., Beauclair L., Geiser R., Etienne P. A pilot study of magnesium aspartate hydrochloride (Magnesiocard) as a mood stabilizer for rapid cycling bipolar affective disorder patients. Prog. Neuropsychopharmacol. Biol. Psychiatry. 1990. 14: 171-180.
7. Cox I.M., Campbell M.J., Dowson D. Red blood cell magnesium and chronic fatigue syndrome. Lancet. 1991. 337: 757-760.
8. Dakshinamurti K., Paulose C.S., Viswanathan M., Siow Y.L. Neuroendocrinology of pyridoxine deficiency. Neurosci. Biobehav. Rev. 1988. 12: 189-193.
9. Detke M.J., Lucki I. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav. Brain Res. 1996. 73(1-2): 43-46.
10. Eby G.A., Eby K.L. Rapid recovery from major depression using magnesium treatment. Med. Hypotheses. 2006. 67(2): 362-370.
11. Fromm L., Heath D.L., Vink R., Nimmo A.J. Magnesium attenuates post-traumatic depression/anxiety following diffuse traumatic brain injury in rats. J. Am. Coll. Nutr. 2004. 23(5): 529S-533S.
12. Grunze H., Waiden J. Reduction of the frequency of occurrence of low magnesium induced field potentials in the hippocampus slice preparation of guinea pigs: a good screening tool for calcium antagonistic effects of anticonvulsant and antipsychotic drugs. Magnes. Res. 1997. 10: 119-126.
13. 2+ supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry. 2002. 35: 135-143.
14. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 2000. 23: 477-501.
15. 2O) solution and pyridoxine hydrochloride on erythrocyte magnesium depletion and behaviour of rats after three-month alcoholisation. Magnes. Res. 2002. 15(3-4): 179-189.
16. th International Magnesium Symposium and Joint Meeting of the Japanese Society for Magnesium Research. J. Japan. Soc. Magnes. Res. 2006. 25(2): 99.
17. Kantak K.M. Magnesium deficiency alters aggressive behavior and catecholamine function. Behav. Neurosci. 1988. 102:304-311.
18. Kiss Z. Clinical importance and bioavalaibility of different magnesium salts after oral administration to humans. Magnes. Res. 2006. 19(1): 72.
19. Lavioe P.A., Beauchamp G., Elie R. Tricyclic antidepressants inhibit voltage-dependent calcium channels and Na-Ca exchange in rat brain cortex synaptosomes. Can. J. Physiol. Pharmacol. 1990. 68: 1414-1418.
20. Levine J., Stein D., Rapoport A., Kurtzman L. High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients. Neuropsychobiology. 1999. 39: 63-70.
21. McCoy M.A., Young P.B., Hudson A.J., Davison G., Kennedy D.G. Regional brain monoamine concentrations and their alterations in bovine hypomagnesaemic tetany experimentally induced by a magnesium-deficient diet. Res. Vet. Sci. 2000. 69(3): 301-307.
22. Murck H. Atypical depression spectrum disorder - neurobiology and treatment. Acta Neuropsychiatrica. 2003. 15: 227-241.
23. 2+ reduces ACTH secretion and enhances spindle power without changing delta power during sleep in men - possible therapeutic implications. Psychopharmacology. 1998. 137: 247-252.
24. Pellow S., Chopin P., File S., Briley H. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Res. Method. 1985. 14(3): 149-167.
25. 6 status in the rat. J. Am. Coll. Nutr. 1997. 16(4): 352-356.
26. Poleszak E., Szewczyk B., Kedzierska E., Wlaz P., Pilc A., Nowak G. Antidepressant- and anxiolytic-like activity of magnesium in mice. Pharmacol. Biochem. Behav. 2004. 78: 7-12.
27. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature. 1977. 266(21): 730-732.
28. Rasmussen H.H., Mortensen P.B., Jensen I.W. Depression and magnesium deficiency. Int. J. Psychiatry Med. 1989. 19: 57-63.
29. Shiekhattar R., Aston-Jones G. NMDA-receptor-mediated sensory responses of brain noradrenergic neurons are suppressed by in vivo concentrations of extracellular magnesium. Synapse. 1992. 10: 103-109.
30. Singewald N., Sinner C., Hetzenauer A., Sartori S.B., Murck H. Magnesium-deficient diet alters depression- and anxiety-related behavior in mice - influence of desipramine and Hypericum perforatum extract. Neuropharmacology. 2004. 47: 1189-1197.